Evaluation of a decentralized investigational drug service pharmacist in a cancer clinical trial infusion unit.

Christina Baroody Melissa Sandler Christine Hong Yazan F Madanat Stefanie Conley

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)

This pilot study demonstrated that a decentralized IDS pharmacist in an oncology clinical trial infusion unit improved accessibility to an IDS pharmacist, increased pharmacy consults relevant to patient care and optimized centralized pharmacists medication distribution workflow. Further studies are needed to evaluate patient benefits from implementing decentralized IDS pharmacist in direct patient care activities.

Keyphrases

clinical trial
phase ii
healthcare
low dose
mental health
open label
study protocol
double blind
palliative care
papillary thyroid
emergency department
young adults
phase iii
quality improvement
general practice